Shopping Cart 0
Cart Subtotal
AED 0

Global 3D printed drugs Market Size Study, By Drug (Spritam and Others) and Regional (US and Rest of the World) Forecasts, 2017-2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 14497

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 20369
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global 3D printed drugs industry valued approximately USD XX Million in 2016 is anticipated to grow with a healthy growth rate of XX% over the forecast period 2017-2025. 3D printed drugs are created by 3D printing technology which are used to treat patients who suffering from dysphagia. This medicine is easy to swallow and helpful for patients suffering from dysphagia. Increase in demand for fast soluble drugs which can disperse easily in the mouth is the key factor that gives growth to the global 3D printed drugs market. Furthermore, rising incidence of epilepsy cases, continues technological developments in 3D printing technique, and growing awareness for 3D printing technology in the developing countries are the major drivers of the market. However, concerns such as blueprint hacking and mislabeling of blueprint are going to hamper the market growth. Moreover, dicey regulatory scenario is another major restraint.

In 2016, Spritam is first 3D printed drug receive approval from the FDA. It is launched by Aprecia Pharmaceuticals. This medicine is currently active only in the U.S. region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

Drug:

? Spritam

? Others

Regions:

? North America

o U.S.

? Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2015

Base year 2016

Forecast period 2017 to 2025

Some of the key manufacturers involved in the market Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the 3D printed drugs Market Study:

? Key Consulting Companies & Advisors

? Large, medium-sized, and small enterprises

? Venture capitalists

? Value-Added Resellers (VARs)

? Third-party knowledge providers

? Investment bankers

? Investors

READ MORE

Table Of Content

Scope

Chapter 1. Research Methodology

1.1. Research Process

1.1.1. Data Mining

1.1.2. Analysis

1.1.3. Market Estimation

1.1.4. Validation

1.1.5. Publishing

1.2. Research Assumption

Chapter 2. Global 3D printed drugs Market Definition & Scope

2.1. Objective of The Study

2.2. Market Definition

2.3. Scope of The Study

2.4. Years Considered for The Study

2.5. Currency Conversion Rates

2.6. Report Limitation

Chapter 3. Executive Summary

3.1. Key Trends

3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)

Chapter 4. Global 3D printed drugs Industry Dynamics

4.1. Growth Prospects

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.2. Industry Analysis

4.2.1. Porters 5 Force Model

4.2.2. PEST Analysis

4.2.3. Value Chain Analysis

4.3. Analyst Recommendation & Conclusion

Chapter 5. Global 3D printed drugs Market by Drugs

5.1. Market Snapshot

5.2. 3D printed drugs Market, Sub Segment Analysis

5.2.1. Spritam

5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.2. Others

5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

Chapter 6. Global 3D printed drugs Market, Regional Analysis

6.1. 3D printed drugs Market, Regional Market Snapshot (2015-2025)

6.2. North America 3D printed drugs Market Snapshot

6.2.1. U.S. 3D printed drugs Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.1.2. Spritam breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

6.3. Rest of The World 3D printed drugs Market Snapshot

6.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.3.2. Spritam breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

Chapter 7. Competitive Intelligence

7.1. Company Market Share (Subject to Data Availability)

7.2. Top Market Strategies

7.3. Company Profiles

7.3.1. Aprecia Pharmaceuticals

7.3.1.1. Overview

7.3.1.2. Financial (Subject to Data Availability)

7.3.1.3. Product Summary

7.3.1.4. Recent Developments

7.3.2. GlaxoSmithKline Plc.

7.3.3. Hewlett Packard Caribe

7.3.4. BV

7.3.5. FabRx Ltd

7.3.6. 3D Printer Drug Machine


List Of Figure

List of Figures

FIG 1. GLOBAL 3D PRINTED DRUGS MARKET, RESEARCH METHODOLOGY

FIG 2. GLOBAL 3D PRINTED DRUGS MARKET, MARKET ESTIMATION TECHNIQUES

FIG 3. MARKET SIZE ESTIMATES & FORECAST METHODS

FIG 4. GLOBAL 3D PRINTED DRUGS MARKET, KEY TRENDS 2016

FIG 5. GLOBAL 3D PRINTED DRUGS MARKET, GROWTH PROSPECTS 2017-2025

FIG 6. GLOBAL 3D PRINTED DRUGS MARKET, PORTERS 5 FORCE MODEL

FIG 7. GLOBAL 3D PRINTED DRUGS MARKET, PEST ANALYSIS

FIG 8. GLOBAL 3D PRINTED DRUGS MARKET, VALUE CHAIN ANALYSIS

FIG 9. GLOBAL 3D PRINTED DRUGS MARKET BY SEGMENT 1, 2015 & 2025 (USD BILLION)

FIG 10. GLOBAL 3D PRINTED DRUGS MARKET BY SEGMENT2, 2015 & 2025 (USD BILLION)

FIG 11. GLOBAL 3D PRINTED DRUGS MARKET, REGIONAL SNAPSHOT 2015 & 2025

FIG 12. NORTH AMERICA 3D PRINTED DRUGS MARKET 2015 & 2025 (USD BILLON)

FIG 13. EUROPE 3D PRINTED DRUGS MARKET 2015 & 2025 (USD BILLON)

FIG 14. ASIA PACIFIC 3D PRINTED DRUGS MARKET 2015 & 2025 (USD BILLON)

FIG 15. LATIN AMERICA 3D PRINTED DRUGS MARKET 2015 & 2025 (USD BILLON)

FIG 16. 3D PRINTED DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)


List Of Table

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL 3D PRINTED DRUGS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL 3D PRINTED DRUGS MARKET

TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD MILLION/BILLION)

TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD MILLION/BILLION)

TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD MILLION/BILLION)

TABLE 9. 3D PRINTED DRUGS MARKET BY SEGMENT 1, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 10. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 11. 3D PRINTED DRUGS MARKET BY SEGMENT 2, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 12. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 13. 3D PRINTED DRUGS MARKET BY SEGMENT 3, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 14. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 15. 3D PRINTED DRUGS MARKET BY SEGMENT 4, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 16. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 17. 3D PRINTED DRUGS MARKET BY SEGMENT 5, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 18. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 19. 3D PRINTED DRUGS MARKET BY SEGMENT 6, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 20. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 21. 3D PRINTED DRUGS MARKET BY SEGMENT 7, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 22. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 23. 3D PRINTED DRUGS MARKET BY SEGMENT 8, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 24. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 25. 3D PRINTED DRUGS MARKET BY SEGMENT 9, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 26. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 27. 3D PRINTED DRUGS MARKET BY SEGMENT 10, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 28. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 29. 3D PRINTED DRUGS MARKET BY SEGMENT 11, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 30. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 31. U.S. 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 32. U.S. 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 33. U.S. 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 34. CANADA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 35. CANADA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 36. CANADA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 37. UK 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 38. UK 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 39. UK 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 40. GERMANY 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 41. GERMANY 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 42. GERMANY 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 43. ROE 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 44. ROE 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 45. ROE 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 46. CHINA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 47. CHINA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 48. CHINA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 49. INDIA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 50. INDIA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 51. INDIA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 52. JAPAN 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 53. JAPAN 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 54. JAPAN 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 55. ROAPAC 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 56. ROAPAC 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 57. ROAPAC 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 E 2015-2025 (USD MILLION/BILLION)

TABLE 58. BRAZIL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 59. BRAZIL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 60. BRAZIL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 61. MEXICO 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 62. MEXICO 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT1 2015-2025 (USD MILLION/BILLION)

TABLE 63. MEXICO 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 64. ROLA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 65. ROLA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 66. ROLA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

TABLE 67. ROW 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)

TABLE 68. ROW 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)

TABLE 69. ROW 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

GlaxoSmithKline Plc.

Hewlett Packard Caribe

BV

FabRx Ltd

3D Printer Drug Machine